ArticleExperimental hematology & oncology2022

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes.

Junying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.